FindTrial
Sign In

COVID-19 and liver injury in patients with or without underlying liver disease: A multi-centre retrospective-prospective observational study

COVID-19 and liver injury in patients with or without underlying liver disease: A multi-centre retrospective-prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/06/025802
Enrollment
314
Registered
2020-06-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Max Super Speciality Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients infected with SARS-CoV-2 and admitted to the COVID-19 ward/ICU of Max Hospital Saket (either in East Wing , Max Super Specialty Hospital, Saket or MAX Smart Super Specialty Hospital, Saket) between 1/4/2020 to 30/6/2020 (retrospective data between 1/4/2020- 30/4/2020 & prospective data from approval till 30/6/2020), will be included.

Exclusion criteria

Exclusion criteria: 1. Patients less that 18 years old with COVID-19 2. Pregnant ladies with COVD-19 3. Unwilling to give consent for inclusion

Design outcomes

Primary

MeasureTime frame
â?¢ Prevalence of liver injury in patients infected with SARS-CoV-2 virus. â?¢ Prevalence of new liver injury in patients having COVD-19 infection over underlying liver dis-eases. Timepoint: 4 weeks—

Secondary

MeasureTime frame
â?¢ Incidence of Acute liver failure â?¢ Incidence of ACLF â?¢ Mortality Timepoint: 4-8 weeks—

Countries

India

Contacts

Public ContactRajesh Saxena

Max Super Speciality Hospital

Saroj.kumar@maxhealthcare.com9999325464

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026